Prevalence of overlap of antineutrophil cytoplasmic antibody associated vasculitis with systemic autoimmune diseases: an unrecognized example of poliautoimmunity.


Journal

Clinical rheumatology
ISSN: 1434-9949
Titre abrégé: Clin Rheumatol
Pays: Germany
ID NLM: 8211469

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 08 06 2018
accepted: 09 07 2018
revised: 05 07 2018
pubmed: 15 7 2018
medline: 5 6 2019
entrez: 15 7 2018
Statut: ppublish

Résumé

We aimed to estimate the frequency of overlap of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) with systemic autoimmune diseases. Retrospective single-center study to identify patients with AAV diagnosis and concomitant autoimmune systemic diseases, simultaneously, before or after the diagnosis of AAV. Sociodemographic characteristics, such as comorbidities; follow-up time; type of AAV; disease duration; relapses; treatment and response; clinical, serological, and histological characteristics; disease activity and damage; prognosis; dialysis requirements, and death were assessed. Twenty-eight of two hundred and forty-seven patients (11.3%) with AAV had a concomitant diagnosis of autoimmune disease. The predominant AAV type was renal-limited vasculitis (39%), followed by granulomatosis with polyangiitis (29%), mycroscopic polyangiitis (25%), and eosinophilic granulomatosis with polyangiitis (7%). Mean age at AAV diagnosis was 50 ± 17 years and 24/28 were ANCA positive. The main clinical manifestations were renal (79%), otorhinolaryngologic (43%), and pulmonary and peripheral neuropathy (32%). Sixteen patients (57%) experienced partial or total remission at a median follow-up of 34 months, and four patients (14%) died. The most frequent autoimmune disease overlapped was rheumatoid arthritis (39%), followed by Sjögren's syndrome and systemic sclerosis (14%), mixed connective tissue disease (11%), systemic lupus erythematosus and juvenile idiopathic arthritis (7%), and ankylosing spondylitis and IgG4-related disease (4%). In nine patients (32%), both diagnoses were simultaneous; in the rest, median time elapsed between the autoimmune disease and AAV diagnosis was 173 months. The prevalence of overlap AAV with other autoimmune diseases was low. The most common AAV phenotype was renal-limited vasculitis, and the most frequent overlap disease was rheumatoid arthritis.

Identifiants

pubmed: 30006919
doi: 10.1007/s10067-018-4212-1
pii: 10.1007/s10067-018-4212-1
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

97-106

Références

J Am Soc Nephrol. 2011 Jul;22(7):1343-52
pubmed: 21719792
Br J Dermatol. 1996 Mar;134(3):407-10
pubmed: 8731661
J Rheumatol. 1996 May;23(5):826-30
pubmed: 8724292
Medicine (Baltimore). 2013 Jan;92(1):1-9
pubmed: 23263715
Curr Rheumatol Rep. 2015 Mar;17(3):12
pubmed: 25740705
Am J Kidney Dis. 2007 Nov;50(5):821-5
pubmed: 17954295
Rheumatology (Oxford). 2016 Dec;55(12):2271-2273
pubmed: 27686100
Intern Med J. 2016 Jun;46(6):745-6
pubmed: 27257153
Hum Pathol. 2013 Nov;44(11):2432-7
pubmed: 23993777
Rheumatology (Oxford). 2013 Oct;52(10):1824-31
pubmed: 23832959
Case Rep Nephrol Dial. 2015 May 05;5(2):113-7
pubmed: 26120576
Springerplus. 2015 Feb 01;4:50
pubmed: 25664229
Lupus. 2003;12(9):651-8
pubmed: 14514126
Eur Respir J. 2011 Jun;37(6):1503-13
pubmed: 21071471
Br J Rheumatol. 1992 Feb;31(2):121-3
pubmed: 1737227
Autoimmun Rev. 2017 Oct;16(10):1036-1043
pubmed: 28780079
Clin Rheumatol. 2016 Jun;35(6):1457-62
pubmed: 26951256
Clin Exp Rheumatol. 1999 Jan-Feb;17(1):91-4
pubmed: 10084039
Am J Kidney Dis. 2012 Mar;59(3):439-43
pubmed: 22189036
Eur J Rheumatol. 2016 Sep;3(3):122-133
pubmed: 27733943
Br J Rheumatol. 1998 Dec;37(12):1287-91
pubmed: 9973150
J Rheumatol. 1996 Sep;23(9):1636-40
pubmed: 8877938
Medicine (Baltimore). 2016 May;95(22):e3748
pubmed: 27258503
Medicine (Baltimore). 2016 Aug;95(34):e4633
pubmed: 27559962
Autoimmunity. 2005 May;38(3):219-23
pubmed: 16126510
J Rheumatol. 2003 Jun;30(6):1248-52
pubmed: 12784398
Medicine (Baltimore). 2007 Jul;86(4):242-51
pubmed: 17632266
J Nephropathol. 2017 Mar;6(2):58-62
pubmed: 28491854
Ann Rheum Dis. 2006 Mar;65(3):410-1
pubmed: 16474034
N Engl J Med. 2012 Jul 19;367(3):214-23
pubmed: 22808956
Immunol Res. 2016 Dec;64(5-6):1243-1246
pubmed: 27618831
Autoimmun Rev. 2015 Aug;14(8):742-50
pubmed: 25916811
Saudi J Kidney Dis Transpl. 2015 Mar;26(2):359-62
pubmed: 25758890
Kidney Int. 2009 Aug;76(3):307-17
pubmed: 19404274
Case Rep Nephrol. 2016;2016:9340524
pubmed: 27891268
Dis Markers. 2009;27(5):217-23
pubmed: 20037209
Clin Exp Ophthalmol. 2004 Aug;32(4):441-3
pubmed: 15281986
Tohoku J Exp Med. 2017;242(2):109-114
pubmed: 28592713
Joint Bone Spine. 2010 Jul;77(4):349-50
pubmed: 20471896
Clin Exp Rheumatol. 2003 Jul-Aug;21(4):528
pubmed: 12942715

Auteurs

Eduardo Martín-Nares (E)

Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga No. 15, Col. Sección XVI, Tlalpan, CP 14000, Mexico City, Mexico.

Diego Zuñiga-Tamayo (D)

Department of Pathology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga No. 15, Col. Sección XVI, Tlalpan, CP 14000, Mexico City, Mexico.

Andrea Hinojosa-Azaola (A)

Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga No. 15, Col. Sección XVI, Tlalpan, CP 14000, Mexico City, Mexico. andreaha@yahoo.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH